This company has been marked as potentially delisted and may not be actively trading. Aileron Therapeutics (ALRN) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Aileron Therapeutics Earnings Summary Aileron Therapeutics issued Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.45, which missed analysts' consensus estimates of -$0.25 by $0.20. With a trailing EPS of -$3.12, Aileron Therapeutics' earnings are expected to grow next year, from ($1.56) to ($1.41) per share. Latest Q2 Earnings DateAug. 14EstimatedConsensus EPS (Aug. 14) -$0.25 Actual EPS (Aug. 14) -$0.45 Missed By -$0.20 Q2 2024 Earnings ResourcesQ2 2024 Earnings Report Quarterly Report (10-Q) Press Release (8-K)Powered by Get Aileron Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aileron Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataALRN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Aileron Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.56) EPSNext Year EPS Consensus Estimate ($1.41) EPS Aileron Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/14/2024--$0.25-$0.45 -$0.20-$0.45--5/20/2024--$0.14-$0.86 -$0.72-$0.86--4/15/2024Q4 2023--$1.54 -$1.54-$1.54--10/13/2023Q3 2023--$0.40 -$0.40-$0.40--8/11/2023Q2 2023--$0.39 -$0.39-$0.39-- Aileron Therapeutics Earnings - Frequently Asked Questions When did Aileron Therapeutics announce their last quarterly earnings? Aileron Therapeutics (NASDAQ:ALRN) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on ALRN's earnings history. Did Aileron Therapeutics beat their earnings estimates last quarter? In the previous quarter, Aileron Therapeutics (NASDAQ:ALRN) missed the analysts' consensus estimate of ($0.25) by $0.20 with a reported earnings per share (EPS) of ($0.45). Learn more on analysts' earnings estimate vs. ALRN's actual earnings. How much profit does Aileron Therapeutics generate each year? Aileron Therapeutics (NASDAQ:ALRN) has a recorded net income of -$15.73 million. ALRN has generated -$3.12 earnings per share over the last four quarters. What is Aileron Therapeutics' EPS forecast for next year? Aileron Therapeutics' earnings are expected to grow from ($1.56) per share to ($1.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies VTYX Earnings NVCT Earnings PBYI Earnings ENGN Earnings ELDN Earnings EDIT Earnings ACTU Earnings SLS Earnings LFVN Earnings SPRO Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:ALRN) was last updated on 6/20/2025 by MarketBeat.com Staff From Our PartnersThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aileron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aileron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
